Multimodal Ultrasound for Lymphoma Classification and Treatment Response Prediction
Key facts
- Who runs it
- Chinese PLA General Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 1 Jan 2026
- Expected to end
- Dec 2031
- Type of study
- Observational
- Treatments tested
- Multimodal Ultrasound Examination
- Record updated
- 17 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age 18 years or older
- Histopathologically confirmed lymphoma
- Newly diagnosed and previously untreated, with no prior radiotherapy, chemotherapy, targeted therapy, immunotherapy, or other systemic antitumor treatment before enrollment
- At least one superficial or otherwise accessible lesion that can be clearly evaluated by ultrasound, such as a cervical, axillary, or inguinal lymph node, with an adequate acoustic window allowing stable acquisition of all five ultrasound modalities
- Expected survival of more than 3 months
- No contraindication to the use of ultrasound contrast agents
- Willingness to undergo multimodal ultrasound examinations before, during, and after treatment and provision of written informed consent
Who cannot take part
- Unstable angina or acute myocardial infarction within the previous 1 week
- Known history of hypersensitivity to any component of the ultrasound contrast agent (sulfur hexafluoride microbubbles)
- Known right-to-left cardiac shunt, severe pulmonary hypertension with pulmonary artery pressure greater than 90 mmHg, or uncontrolled hypertension
- Acute respiratory distress syndrome or severe respiratory insufficiency
- Target lesion located too deeply or obscured by gas or bone, preventing acquisition of a stable ultrasound imaging plane
- Pregnancy or breastfeeding
- Inability, in the investigator's judgment, to cooperate with the complete examination procedure or complete the required follow-up
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, multicenter, observational cohort study aims to evaluate whether multimodal ultrasound can support the noninvasive classification of lymphoma and the early prediction of treatment response.
Read full original descriptionShow less
Adults with newly diagnosed and previously untreated lymphoma will undergo standardized multimodal ultrasound examinations before treatment, after the first treatment cycle, after the fourth treatment cycle, and during follow-up. Ultrasound examinations will include B-mode ultrasound, color Doppler flow imaging, contrast-enhanced ultrasound, super-resolution contrast-enhanced ultrasound, and ultrasound viscoelasticity imaging. Clinical, laboratory, pathological, molecular, treatment, and follow-up information will also be collected.
The study will investigate differences in ultrasound characteristics among lymphoma subtypes, evaluate changes in ultrasound features during treatment, and develop and validate prediction models integrating imaging and clinical information. The main hypothesis is that multimodal ultrasound features and their early treatment-related changes reflect the biological heterogeneity of lymphoma and can improve noninvasive lymphoma classification and early prediction of treatment response.
The group in the trial
- Newly Diagnosed Untreated Lymphoma Cohort
Adults with pathologically confirmed, newly diagnosed, previously untreated lymphoma who undergo longitudinal multimodal ultrasound examinations and clinical follow-up according to the study protocol.
Treatment: Multimodal Ultrasound Examination
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multimodal Ultrasound-Based Intelligent Classification and Treatment Response Prediction in the Dynamic Evolution of Lymphoma
- Record updated
- 17 November 2026